{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:11:59Z","timestamp":1761765119764},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1007\/s00296-009-0859-x","type":"journal-article","created":{"date-parts":[[2009,1,31]],"date-time":"2009-01-31T05:16:24Z","timestamp":1233378984000},"page":"1499-1502","source":"Crossref","is-referenced-by-count":57,"title":["Rituximab in life threatening antisynthetase syndrome"],"prefix":"10.1007","volume":"29","author":[{"given":"E.","family":"Vandenbroucke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. C.","family":"Grutters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Altenburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. G.","family":"Boersma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. J.","family":"ter Borg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. M. M.","family":"van den Bosch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,2,1]]},"reference":[{"key":"859_CR1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1297-319X(03)00012-5","volume":"70","author":"A Imbert-Masseau","year":"2003","unstructured":"Imbert-Masseau A, Hamidou M, Agard C, Grolleau J-Y, Ch\u00e9rin P (2003) Antisynthetase syndrome. Joint Bone Spine 70:161\u2013168. doi: 10.1016\/S1297-319X(03)00012-5","journal-title":"Joint Bone Spine"},{"key":"859_CR2","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/art.10794","volume":"47","author":"I Marie","year":"2002","unstructured":"Marie I, Hachulla E, Ch\u00e9rin P et al (2002) Interstitial lung disease in polymyositis and dermatomyositis. Arthritis Rheum 47:614\u2013622. doi: 10.1002\/art.10794","journal-title":"Arthritis Rheum"},{"key":"859_CR3","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/08916930600623791","volume":"39","author":"R La Corte","year":"2006","unstructured":"La Corte R, Lo Mo Naco A, Locaputo A, Dolzani F, Trotta R (2006) In patients with antisynthetase syndrome the occurrence of anti-Ro\/SSA antibodies causes a more severe interstitial lung disease. Autoimmunity 39:249\u2013253. doi: 10.1080\/08916930600623791","journal-title":"Autoimmunity"},{"key":"859_CR4","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3346\/jkms.2003.18.1.131","volume":"18","author":"HK Chang","year":"2003","unstructured":"Chang HK, Lee DH (2003) Successful combination therapy of cyclosporine and methotrexate for refractory polymyositis with anti-Jo-1 antibody. J Korean Med Sci 18:131\u2013134","journal-title":"J Korean Med Sci"},{"key":"859_CR5","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00296-006-0289-y","volume":"27","author":"M Jankowska","year":"2007","unstructured":"Jankowska M, Butto B, Debska-Slizien A, Rutkowski B (2007) Beneficial effect of treatment with cyclosporine A in a case of refractory antisynthetase syndrome. Rheumatol Int 27:775\u2013780. doi: 10.1007\/s00296-006-0289-y","journal-title":"Rheumatol Int"},{"key":"859_CR6","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/ard.2005.045898","volume":"65","author":"L Bulhart","year":"2006","unstructured":"Bulhart L, Waldburger J-M, Gabay C (2006) Rituximab in the treatment of antisynsthetase syndrome. Ann Rheum Dis 65:974\u2013975. doi: 10.1136\/ard.2005.045898","journal-title":"Ann Rheum Dis"},{"key":"859_CR7","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/art.20849","volume":"52","author":"TD Levine","year":"2005","unstructured":"Levine TD (2005) Rituximab in the treatment of dermatomyositis. An open-label pilot study. Arthritis Rheum 52:601\u2013607. doi: 10.1002\/art.20849","journal-title":"Arthritis Rheum"},{"key":"859_CR8","first-page":"1369","volume":"32","author":"O Lambotte","year":"2005","unstructured":"Lambotte O, Koth R, Maigne G, Blanc F-X, Goujard C, Delfraissy J-F (2005) Efficacy of rituximab in refractory polymositis. J Rheumatol 32:1369\u20131370","journal-title":"J Rheumatol"},{"key":"859_CR9","first-page":"1864","volume":"34","author":"CC Mok","year":"2007","unstructured":"Mok CC, Ho LY, To CH (2007) Rituximab for refractory polymyositis: an open label prospective study. J Rheumatol 34:1864\u20131868","journal-title":"J Rheumatol"},{"key":"859_CR10","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/art.10947","volume":"48","author":"GJ Silverman","year":"2003","unstructured":"Silverman GJ, Weisman S (2003) Rituximab therapy and autoimmune disorders. Prospects for anti-B cell therapy. Arthritis Rheum 48:1484\u20131492. doi: 10.1002\/art.10947","journal-title":"Arthritis Rheum"},{"key":"859_CR11","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1056\/NEJMoa032534","volume":"350","author":"JC Edwards","year":"2004","unstructured":"Edwards JC, Szczepanski L, Szechinski J et al (2004) Efficacy of B-cell-Targeted Therapy with Rituximab in Patients with Rheumatoid Arthirtis. N Engl J Med 350:2572\u20132581. doi: 10.1056\/NEJMoa032534","journal-title":"N Engl J Med"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-009-0859-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-009-0859-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-009-0859-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T07:16:15Z","timestamp":1559027775000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-009-0859-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,1]]},"references-count":11,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["859"],"URL":"https:\/\/doi.org\/10.1007\/s00296-009-0859-x","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,1]]}}}